Loading your page…
Anemia;Cancer;Kidney Failure, Chronic
Marketing Authorisation Holder: Amgen Europe B.V.
EMA Authorisation: 08/06/2001
INN: darbepoetin alfa
AI Drug & Interaction Analysis
Free account required
Ask Osler about Aranesp: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.
